OROMAB Trademark

Trademark Overview

On Saturday, July 20, 2019, a trademark application was filed for OROMAB with the United States Patent and Trademark Office. The USPTO has given the OROMAB trademark a serial number of 88525621. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by ORUM THERAPEUTICS INC.. The OROMAB trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

monoclonal antibodies for scientific purposes

medical studies in the field of antibodies for scientific purposes; medical research in the field of antibodies
oromab

General Information

Serial Number88525621
Word MarkOROMAB
Filing DateSaturday, July 20, 2019
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6674784
Registration DateTuesday, March 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements

Goods and Servicesmonoclonal antibodies for scientific purposes
Goods and Servicesmedical studies in the field of antibodies for scientific purposes; medical research in the field of antibodies

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameORUM THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR
Party NameORUM THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR
Party NameORUM THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 1, 2021ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, December 1, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 26, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, August 25, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, August 9, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sunday, August 1, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 12, 2021CASE RETURNED TO EXAMINATION
Monday, July 12, 2021NOTICE OF ALLOWANCE CANCELLED
Thursday, April 1, 2021ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, April 1, 2021PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, April 1, 2021ASSIGNED TO PETITION STAFF
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 10, 2021TEAS PETITION TO DIRECTOR RECEIVED
Friday, January 8, 2021EXTENSION 2 GRANTED
Friday, January 8, 2021EXTENSION 2 FILED
Friday, January 8, 2021TEAS EXTENSION RECEIVED
Wednesday, July 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020EXTENSION 1 GRANTED
Monday, July 20, 2020EXTENSION 1 FILED
Monday, July 20, 2020TEAS EXTENSION RECEIVED
Tuesday, January 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 17, 2019ASSIGNED TO LIE
Wednesday, October 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, October 9, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 9, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, October 9, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 8, 2019ASSIGNED TO EXAMINER
Tuesday, July 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, July 24, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

oromab antibodies field medical purposes scientific research studies monoclonal